Protective pathways against colitis mediated by appendicitis and appendectomy

Clinical and Experimental Immunology

Volumn 165, Issue 3, 2011, Pages 393-400

  Cheluvappa, R ^a   Luo, A S ^a   Palmer, C ^b   Grimm, M C ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Appendectomy; Appendicitis; Colitis; Th17 system

Indexed keywords

APOLIPOPROTEIN C3; CHEMOKINE RECEPTOR CCR5; GLUCOSE TRANSPORTER 5; IRGM PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; PROSTAGLANDIN E RECEPTOR 4; PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APPENDECTOMY; APPENDICITIS; ARTICLE; CELL FUNCTION; COLITIS; CONTROLLED STUDY; DESCENDING COLON; DOWN REGULATION; FALSE POSITIVE RESULT; GENE ACTIVATION; GENE EXPRESSION; GENE REPRESSION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION;

AGE FACTORS; ANIMALS; APPENDECTOMY; APPENDICITIS; CHEMOKINE CCL20; COLITIS, ULCERATIVE; COLON; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GTP-BINDING PROTEINS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; MALE; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLATELET FACTOR 4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; TIME FACTORS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UP-REGULATION;

EID: 79960982498     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04434.x     Document Type: Article

References (43)

1. Becker RS, Knight KL. Somatic diversification of immunoglobulin heavy chain VDJ genes: evidence for somatic gene conversion in rabbits. Cell 1990; 63:987-97.
2. Dasso JF, Howell MD. Neonatal appendectomy impairs mucosal immunity in rabbits. Cell Immunol 1997; 182:29-37.
3. Weinstein PD, Anderson AO, Mage RG. Rabbit IgH sequences in appendix germinal centers: VH diversification by gene conversion-like and hypermutation mechanisms. Immunity 1994; 1:647-59.
4. Addiss DG, Shaffer N, Fowler BS, Tauxe RV. The epidemiology of appendicitis and appendectomy in the United States. Am J Epidemiol 1990; 132:910-25.
5. Larner AJ. The aetiology of appendicitis. Br J Hosp Med 1988; 39:540-2.
6. Velanovich V, Satava R. Balancing the normal appendectomy rate with the perforated appendicitis rate: implications for quality assurance. Am Surg 1992; 58:264-9.
7. Marudanayagam R, Williams GT, Rees BI. Review of the pathological results of 2660 appendicectomy specimens. J Gastroenterol 2006; 41:745-9.
8. Koutroubakis IE, Vlachonikolis IG, Kouroumalis EA. Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review. Inflamm Bowel Dis 2002; 8:277-86.
9. Lopez Ramos D, Gabriel R, Cantero Perona J, Moreno Otero R, Fernandez Bermejo M, Mate Jimenez J. Association of MALTectomy (appendectomy and tonsillectomy) and inflammatory bowel disease: a familial case-control study. Rev Esp Enferm Dig 2001; 93:303-14.
10. Andersson RE, Olaison G, Tysk C, Ekbom A. Appendectomy and protection against ulcerative colitis. N Engl J Med 2001; 344:808-14.
11. Radford-Smith GL, Edwards JE, Purdie DM etal. Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut 2002; 51:808-13.
12. Andersson RE, Olaison G, Tysk C, Ekbom A. Appendectomy is followed by increased risk of Crohn's disease. Gastroenterology 2003; 124:40-6.
13. Mizoguchi A, Mizoguchi E, Chiba C etal. Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease. J Exp Med 1996; 183:847-56.
14. Krieglstein CF, Cerwinka WH, Laroux FS etal. Role of appendix and spleen in experimental colitis. J Surg Res 2001; 101:166-75.
15. Farkas SA, Hornung M, Sattler C etal. Preferential migration of CD62L cells into the appendix in mice with experimental chronic colitis. Eur Surg Res 2005; 37:115-22.
16. Watson Ng WS, Hampartzoumian T, Lloyd AR, Grimm MC. A murine model of appendicitis and the impact of inflammation on appendiceal lymphocyte constituents. Clin Exp Immunol 2007; 150:169-78.
17. Mootha VK, Lindgren CM, Eriksson KF etal. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34:267-73.
18. Flach CF, Eriksson A, Jennische E, Lange S, Gunnerek C, Lonnroth I. Detection of elafin as a candidate biomarker for ulcerative colitis by whole-genome microarray screening. Inflamm Bowel Dis 2006; 12:837-42.
19. Seidelin JB, Nielsen OH. Expression profiling of apoptosis-related genes in enterocytes isolated from patients with ulcerative colitis. APMIS 2006; 114:508-17.
20. Cao D, Wilentz RE, Abbruzzese JL, Ho L, Maitra A. Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation. Int J Gastrointest Cancer 2005; 36:39-46.
21. Costello CM, Mah N, Hasler R etal. Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays. PLoS Med 2005; 2:e199.
22. Uthoff SM, Eichenberger MR, Lewis RK etal. Identification of candidate genes in ulcerative colitis and Crohn's disease using cDNA array technology. Int J Oncol 2001; 19:803-10.
23. Dieckgraefe BK, Stenson WF, Korzenik JR, Swanson PE, Harrington CA. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics 2000; 4:1-11.
24. Rivera E, Flores I, Appleyard CB. Molecular profiling of a rat model of colitis: validation of known inflammatory genes and identification of novel disease-associated targets. Inflamm Bowel Dis 2006; 12:950-66.
25. de Buhr MF, Mahler M, Geffers R etal. Cd14, Gbp1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analyses. Physiol Genomics 2006; 25:426-34.
26. Dooley TP, Curto EV, Reddy SP etal. Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays. Inflamm Bowel Dis 2004; 10:1-14.
27. Kristensen NN, Olsen J, Gad M, Claesson MH. Genome-wide expression profiling during protection from colitis by regulatory T cells. Inflamm Bowel Dis 2008; 14:75-87.
28. Bernstein H, Holubec H, Bernstein C etal. Deoxycholate-induced colitis is markedly attenuated in Nos2 knockout mice in association with modulation of gene expression profiles. Dig Dis Sci 2007; 52:628-42.
29. Nakajima A, Wada K, Katayama K etal. Gene expression profile after peroxisome proliferator activator receptor-gamma ligand administration in dextran sodium sulfate mice. J Gastroenterol 2002; 37 (Suppl. 14):62-6.
30. Brazma A. Minimum Information About a Microarray Experiment (MIAME)-successes, failures, challenges. Scientific World J 2009; 9:420-3.
31. Brazma A, Hingamp P, Quackenbush J etal. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001; 29:365-71.
32. Affymetrix Online User Manual - GeneChip® Whole Transcript (WT) Sense Target Labeling Assay. Available at.
33. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003; 31:e15.
34. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003; 100:9440-5.
35. Subramanian A, Tamayo P, Mootha VK etal. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102:15545-50.
36. Brost S, Koschny R, Sykora J etal. Differential expression of the TRAIL/TRAIL-receptor system in patients with inflammatory bowel disease. Pathol Res Pract 2010; 206:43-50.
37. Lundgren BA, Rorsman F, Portela-Gomes GM etal. Identification of complement C3 as an autoantigen in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2010; 22:429-36.
38. Oki M, Ohtani H, Kinouchi Y etal. Accumulation of CCR5+ T cells around RANTES+ granulomas in Crohn's disease: a pivotal site of Th1-shifted immune response? Lab Invest 2005; 85:137-45.
39. Grimm MC, Newman R, Hassim Z etal. Cutting edge: vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by trans-deactivating chemokine receptors. J Immunol 2003; 171:4990-4.
40. Libioulle C, Louis E, Hansoul S etal. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet 2007; 3:e58.
41. Kaser A, Ludwiczek O, Holzmann S etal. Increased expression of CCL20 in human inflammatory bowel disease. J Clin Immunol 2004; 24:74-85.
42. Rioux JD, Silverberg MS, Daly MJ etal. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66:1863-70.
43. Waterman M, Xu W, Stempak JM etal. Distinct and overlapping genetic loci in Crohn's disease and ulcerative colitis: correlations with pathogenesis. Inflamm Bowel Dis 2010 (e-publication ahead of print).